Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: a Doctor-Patient Interaction Approach
Launched by YUJU WU · Mar 9, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new way to help people in rural areas manage their high blood pressure, also known as hypertension. The researchers want to find out if a personalized approach, where doctors and patients work closely together, can improve how patients take care of their health and control their blood pressure over time. They will try different methods to see which ones work best for helping patients manage their condition effectively.
To participate in this study, you need to be between the ages of 65 and 80 and have been diagnosed with high blood pressure. You should live in a rural area and plan to stay there for at least a year. It's important that you are able to understand and communicate during the study, so participants should not have severe cognitive or communication challenges. If you join the trial, you can expect to engage in discussions with your doctor about your health and receive tailored support to help you manage your blood pressure better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed hypertension patients who are permanent residents in rural areas.
- • No plans for long-term relocation within the next year.
- • Willing to participate in this study.
- • No cognitive impairment.
- • No other diseases that significantly affect self-management behavior, such as malignant tumors.
- Exclusion Criteria:
- • Age over 80 years.
- • Having conditions such as stroke, paralysis, or mental disorders that prevent the completion of self-management behaviors.
- • Severe hearing impairment or speech disorders that prevent participation in interviews.
- • Likely to relocate or be away from the local area for an extended period within one year.
About Yuju Wu
Yuju Wu is a dedicated clinical trial sponsor committed to advancing medical research through innovative and rigorous study designs. With a focus on enhancing patient outcomes and safety, Yuju Wu collaborates with healthcare professionals, regulatory bodies, and research institutions to facilitate the development of groundbreaking therapies. Their expertise encompasses a range of therapeutic areas, ensuring adherence to ethical standards and regulatory compliance throughout the trial process. By prioritizing transparency and integrity, Yuju Wu aims to contribute significantly to the scientific community and improve the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported